Comments
Loading...

Cyclacel Pharmaceuticals Analyst Ratings

CYCCPNASDAQ
Logo brought to you by Benzinga Data
$6.29
-3.46-35.49%
At close: -
$8.17
1.8829.89%
After Hours: Mar 3, 4:00 PM EDT

Cyclacel Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:CYCCP | Benzinga

Cyclacel Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cyclacel Pharmaceuticals Corp from these most-recent analyst ratings.

Analyst Ratings for Cyclacel Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cyclacel Pharmaceuticals (CYCCP) stock?

A

There is no price target for Cyclacel Pharmaceuticals

Q

What is the most recent analyst rating for Cyclacel Pharmaceuticals (CYCCP)?

A

There is no analyst for Cyclacel Pharmaceuticals

Q

When was the last upgrade for Cyclacel Pharmaceuticals (CYCCP)?

A

There is no last upgrade for Cyclacel Pharmaceuticals

Q

When was the last downgrade for Cyclacel Pharmaceuticals (CYCCP)?

A

There is no last downgrade for Cyclacel Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Cyclacel Pharmaceuticals (CYCCP)?

A

There is no next analyst rating for Cyclacel Pharmaceuticals.

Q

Is the Analyst Rating Cyclacel Pharmaceuticals (CYCCP) correct?

A

There is no next analyst rating for Cyclacel Pharmaceuticals.

Browse analyst ratings and price targets on all stocks.

People Also Watch